R1 RCM Lowers FY24 Outlook: Projects Revenues Of $2.60B-$2.64B Vs. $2.64B Estimate (Prior View: $2.625B-$2.675B); Sees Adjusted EBITDA Of $625M-$650M (Prior View: $650M-$670M)
R1 RCM Lowers FY24 Outlook: Projects Revenues Of $2.60B-$2.64B Vs. $2.64B Estimate (Prior View: $2.625B-$2.675B); Sees Adjusted EBITDA Of $625M-$650M (Prior View: $650M-$670M)
R1 RCM下調了24財年展望：預計收入爲26.0億美元至26.4億美元，而預期爲26.4億美元（先前觀點：26.25億美元至26.75億美元）；調整後的息稅折舊攤銷前利潤爲6.25億至6.5億美元（先前觀點：6.5億至6.7億美元）
For 2024, R1 now expects to generate:
到2024年，R1現在預計將產生：
- Revenue of $2.60 billion to $2.64 billion
- GAAP operating income of $85 million to $105 million
- Adjusted EBITDA of $625 million to $650 million
- 收入爲26.0億美元至26.4億美元
- GAAP 營業收入爲 8,500 萬美元至 1.05 億美元
- 調整後的息稅折舊攤銷前利潤爲6.25億美元至6.5億美元
The updated guidance reflects the impacts of the Change Healthcare cyberattack on first quarter and expected full year 2024 revenue related to collections timing, claims inflows, and the ability to meet key performance metrics, as well as increased expenses to support our customers.
更新後的指導方針反映了Change Healthcare網絡攻擊對第一季度和2024年全年預期收入的影響，這些收入與收款時間、索賠流入、滿足關鍵績效指標的能力以及支持客戶的支出增加有關。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。